Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP414 | DOI: 10.1530/endoabs.110.EP414

ECEESPE2025 ePoster Presentations Diabetes and Insulin (245 abstracts)

Predictive factors for the use of insulin therapy in gestational diabetes

Zineb Dhaimi 1 , Bensbaa Salma 1 , Nassim Essabah Haraj 1 , Siham El Aziz 1 & Asma Chadli 1


1CHU Ibn Rochd, Laboratory of Neuroscience and Mental Health Faculty of Medicine and Pharmacy, Hassan II University – Casablanca, Morocco, Department of Endocrinology, Diabetology, and Metabolic Diseases, Casablanca, Morocco


JOINT3973

Introduction: In diabetic patients, planning conception is essential to prevent embryofetopathy and the progression of diabetes complications in the mother.

Study Objective: The aim of our study is to analyze the clinical and metabolic profile of a group of pregnant women with Gestational Diabetes (GD) and to determine the predictive factors for the use of insulin therapy.

Materials and Methods: This is a retrospective study conducted in our Department, including 368 patients with gestational diabetes. Statistical analysis was performed using SPSS software.

Results: The average age of the patients was 32 years. The average term for diagnosing gestational diabetes was 25.2 weeks of amenorrhea. 22% had a history of GD. Insulin therapy was required in 27% of cases. The average total insulin dose required was 0.5 units/kg/day at the end of third trimester. A regimen with three rapid insulin injections was prescribed for 20 pregnant women. For the remaining patients, a basal-bolus regimen was necessary to achieve targets. The need for insulin therapy was more frequent when GD was diagnosed earlier (<24 weeks) (P = 0.02), in patients older than 35 years (P = 0.02), and with higher fasting blood glucose levels and average glycated hemoglobin levels (P = 0.01).

Conclusion: This study demonstrated that earlier diagnosis of GD, advanced maternal age, and elevated fasting blood glucose levels are predictive factors for insulin therapy, consistent with previous studies. However, a history of macrosomia, recurrence of GD, and diabetic heredity were frequently associated with patients treated with insulin but without statistically significant results.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches